A case-control study revealed that with a 1 pg/ml increase in sPD-1 levels, the risk of HBV-associated hepatocellular carcinoma (HCC) increased 2.02-fold in a multivariate logistic regression model [10]. Here, HOXD13 is linked to hepatocellular carcinoma.